Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Albumins represent highly cross-reactive animal allergens.
Liu Z, Trifonova D, Tulaeva I, Riabova K, Karsonova A, Kozlov E, Elisyutina O, Khaitov M, Focke-Tejkl M, Chen TH, Karaulov A, Valenta R. Liu Z, et al. Among authors: karaulov a. Front Immunol. 2023 Oct 20;14:1241518. doi: 10.3389/fimmu.2023.1241518. eCollection 2023. Front Immunol. 2023. PMID: 37928538 Free PMC article. Review.
Comorbidity defines asthmatic patients' risk of COVID-19 hospitalization: A global perspective.
Skevaki C, Chinthrajah RS, Fomina D, Rohde G, Cao S, He Z, Serdotetskova S, Seidemann C, Grünewaldt A, Vengadeswaran A, Xie M, Karsonova A, Karaulov A, Nadeau KC, Chung HR, Renz H. Skevaki C, et al. Among authors: karaulov a. J Allergy Clin Immunol. 2023 Jan;151(1):110-117. doi: 10.1016/j.jaci.2022.09.039. Epub 2022 Nov 3. J Allergy Clin Immunol. 2023. PMID: 36336123 Free PMC article.
Treatment of atopic dermatitis with upadacitinib: adcare single center experience.
Fomina DS, Mukhina OA, Mikhailova VI, Lebedkina MS, Sedova EL, Bobrikova EN, Elisyutina OG, Fedenko ES, Nurpeisov TT, Karaulov AV, Lysenko MA, Ensina LFC. Fomina DS, et al. Among authors: karaulov av. Front Med (Lausanne). 2024 Apr 17;11:1385720. doi: 10.3389/fmed.2024.1385720. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38695023 Free PMC article.
Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period.
Fomina DS, Lebedkina MS, Iliukhina AA, Kovyrshina AV, Shelkov AY, Andreev SS, Chernov AA, Dolzhikova IV, Kruglova TS, Andrenova GV, Tukhvatulin AI, Shcheblyakov DV, Karaulov AV, Lysenko MA, Logunov DY, Gintsburg AL. Fomina DS, et al. Among authors: karaulov av. Front Immunol. 2023 Oct 20;14:1259725. doi: 10.3389/fimmu.2023.1259725. eCollection 2023. Front Immunol. 2023. PMID: 37928549 Free PMC article. Clinical Trial.
Features of the Humoral Response to Infection, Vaccination, and Revaccination during COVID-19.
Kombarova SY, Aleshkin AV, Novikova LI, Bochkareva SS, Zatevalov AM, Mekhtiev ER, Mizaeva TE, Basov AA, Borisova OY, Likhanskaya EI, Voropaeva EA, Urban YN, Mitrokhin SD, Shkoda AS, Gushchin VA, Sinyavin AE, Nikiforova MA, Lebedin YS, Karaulov AV. Kombarova SY, et al. Among authors: karaulov av. Bull Exp Biol Med. 2022 Oct;173(6):734-739. doi: 10.1007/s10517-022-05620-1. Epub 2022 Nov 2. Bull Exp Biol Med. 2022. PMID: 36322302 Free PMC article.
200 results